Table 1.
Characteristic | All participants (n = 32) | Seniors (n = 17) | Young adults (n = 15) |
---|---|---|---|
Age, years | 68 (65, 69) | 26 (25, 28) | |
Female gender | 19 (59) | 12 (71) | 7 (47) |
Height, cm | 168 (164, 178) | 167 (163, 170) | 175 (167, 181) |
Weight, kg | 66 (58, 76) | 66 (62, 75) | 67 (57, 77) |
BMI, kg/m2 | 23 (22, 25) | 24 (22, 26) | 22 (19, 23) |
Baseline SBPa, mmHg | 124 (115, 137) | 133 (124, 139) | 115 (108, 124) |
Baseline DBPa, mmHg | 80 (74, 88) | 85 (80, 88) | 78 (73, 81) |
Baseline AVR | 0.87 (0.83, 0.9) | 0.87 (0.83, 0.91) | 0.87 (0.84, 0.9) |
Baseline CRAE, in μm | 188 (177, 194) | 188 (176, 194) | 190 (180, 194) |
Baseline CRVE, in μm | 216 (203, 229) | 209 (203, 234) | 224 (210, 228) |
Baseline measurements are those taken at the first visit before the start of maximal exercise testing
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, AVR arteriolar-to venular diameter ratio, CRAE central retinal arteriolar equivalent, CRVE central retinal venular equivalent
aAvailable in 14 (82 %) and 15 (100 %) seniors and young adults, respectively